High Tower Advisors, LLC Moderna, Inc. Call Options Transaction History

High Tower Advisors, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $20,242 - $33,322	-200 Reduced 11.11%	1,600 $190,000
Q1 2024 May 06, 2024	BUY	$85.37 - $115.44 $153,666 - $207,792	1,800 New	1,800 $191,000
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $13,566 - $19,702	100 New	100 $15,000
Q2 2022 Aug 10, 2022	BUY	$117.13 - $176.59 $11,244 - $16,952	96 Added 2400.0%	100 $1,000
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $62,724 - $116,584	-496 Reduced 99.2%	4 $22,000
Q2 2021 Aug 06, 2021	BUY	$129.91 - $234.98 $25,982 - $46,996	200 Added 66.67%	500 $9,000
Q3 2020 Nov 13, 2020	SELL	$54.34 - $94.85 $16,302 - $28,455	-300 Reduced 50.0%	300 $6,000
Q2 2020 Aug 10, 2020	BUY	$29.67 - $80.0 $5,934 - $16,000	200 Added 50.0%	600 $2,000
Q1 2020 May 21, 2020	BUY	$17.78 - $31.58 $7,112 - $12,632	400 New	400 $2,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.